Assay Detail

CHEMBL4824893

Review assay metadata, readout intent, target linkage, and publication context from the same page.

ADMET

Transactivation of PXR (unknown origin)

ChEMBL ↗

Free Research Context This assay will appear in recent viewed items on this browser. Open the demo workspace to preview project-only review queues.

Research home Demo workspace

Target

Nuclear receptor subfamily 1 group I member 2 (CHEMBL3401) ↗

Open DB target context

Use one target anchor to keep assay intent, target linkage, and tested compound review aligned.

Loading context

Nuclear receptor subfamily 1 group I member 2 (CHEMBL3401) is the working anchor for this assay review. Loading the live Open DB target snapshot…

Primary target Nuclear receptor subfamily 1 group I member 2

CHEMBL3401

Anchored from Assay target.

Protein identity Nuclear receptor subfamily 1 group I member 2

Disease frame Disease evidence pending

Open the live target snapshot or evidence card before reviewing assay metadata so target fit and disease framing stay reusable.

Review focus Open DB context pending

Open the live target snapshot before relying on this target frame across surface handoff.

Open target snapshot Open evidence card Search with this context

Total Activities

Compounds Tested

Activity Types

Assay Parameters

Assay Information

Assay Type	ADMET
Organism	Homo sapiens
Confidence	9 — Direct single protein target
Curated By	Autocuration

Target

Nuclear receptor subfamily 1 group I member 2 (CHEMBL3401) ↗

Type	SINGLE PROTEIN
Organism	Homo sapiens

Publication

Conformational-Analysis-Guided Discovery of 2,3-Disubstituted Pyridine IDO1 Inhibitors.

Cherney EC, Zhang L, Guo W, Huang A, Williams D, Seitz S, Shan W, Zhu X, Gullo-Brown J, Maley D, Lin TA, Hunt JT, Huang C, Yang Z, D'Arienzo CJ, Discenza LN, Ranasinghe A, Grubb MF, Traeger SC, Li X, Johnston KA, Kopcho L, Fereshteh M, Foster KA, Stefanski K, Delpy D, Dhar G, Anandam A, Mahankali S, Padmanabhan S, Rajanna P, Murali V, Mariappan TT, Pattasseri S, Nimje RY, Hong Z, Kempson J, Rampulla R, Mathur A, Gupta A, Borzilleri R, Vite G, Balog A.
ACS Med Chem Lett (2021) 12 : 1143 -1150
PubMed 34267885 · DOI

Activity Statistics

Type	Count	Avg pChEMBL	Best pChEMBL
EC50	1	5.72	5.72

Compounds Tested

Compound	Name	Phase	Activities	Best pChEMBL
CHEMBL4848094	—	—	1	5.72

Activity Data

Compound	Name	Type	Rel.	Value	Units	pChEMBL
CHEMBL4848094	—	EC50	=	1900.0	nM	5.72